RANZCP homepage
Contact
Log in Log in
  • Become a psychiatrist
    • Psychiatry training
      • About Fellowship training
      • Entry requirements
      • How to apply
      • Time, fees and costs
      • See all
    • International specialists
      • Pathways to FRANZCP
      • Applying for specialist assessment
      • Short-term training placements
      • Area of Need positions
      • See all
    • The Psychiatry Interest Forum (PIF)
      • Join PIF
      • Opportunities for PIF members
      • Essay competition
    • What a psychiatrist does
      • Specialist areas in psychiatry
      • A day in the life
      • Information for high school students
      • Posters, presentations & fact sheets
  • Training, exams & assessments
    • Fellowship Program
      • Program overview
      • Stage 1
      • Stage 2
      • Stage 3
      • See all
    • Advanced Training
      • About Advanced Training
      • Addiction psychiatry
      • Adult psychiatry
      • Child & adolescent psychiatry
      • Consultation–liaison psychiatry
      • Forensic psychiatry
      • See all
    • SIMG placements
      • Partial comparability
      • Substantial comparability
      • Extensions, breaks and reviews of comparability
      • See all
    • Exams & assessments
      • Results and timetables
      • Rotation assessments
      • Exams
      • Psychotherapy Written Case
      • Scholarly Project
      • See all
    • Fees
    • For assessors and supervisors
    • Diploma of Psychiatry
    • Help centre & support
    • Go to InTrain
  • Clinical guidelines & publications
    • Journals
      • Australian and NZ Journal of Psychiatry
      • Australasian Psychiatry
      • MEDLINE Complete
      • Behavioural & psychological sciences
      • British Journal of Psychiatry
      • Explore all journals
    • Publication library
      • Clinical guidelines
      • Position statements
      • Codes of ethics & conduct
      • Submissions
      • Explore all documents
    • Explore by topic
      • ADHD
      • Electroconvulsive therapy
      • Ketamine
      • LGBTIQ+
      • See all topics
  • CPD program & membership
    • CPD program
      • CPD overview
      • Program guide and requirements
      • Key dates
      • Peer review groups
      • Practice Peer Review Program
      • See all
    • Support, breaks & deferrals
      • Deferral or exemption of CPD
      • Leave and return to practice
      • Refresher and remediation programs
      • Wellbeing support
      • Mentoring
      • See all
    • Types of membership
      • Fellowship
      • Affiliate membership
      • Associate (trainee) membership
      • See all
    • Member discounts
    • Benefits of membership
    • Fees and payments
    • Conduct and ethics
    • Expense reimbursements
    • Go to MyCPD
  • Events & learning
    • Upcoming events
      • Conferences
      • Webinars
      • Courses
      • See all upcoming events
    • Catch up & learning
      • Past conference talks
      • Webinar recordings
      • Podcasts
      • Explore all catch-up
    • Series
      • rTMS courses
      • ECT courses
      • Psych Matters podcast
    • Go to Learnit
    • Congress 2024
  • Grants, awards & giving
    • Awards & member recognition
      • Branch awards
      • Faculty and section awards
      • RANZCP awards
      • Membership milestones
      • See all
    • Grants
      • Event grants & scholarships
      • Research grants
      • Trainee grants
    • RANZCP Foundation
      • About the Foundation
      • Research highlights
      • Our patrons
      • Donate
  • News & analysis
  • College & committees
    • About the College
      • What the College does
      • Board
      • Executive team
      • Accreditation of the College
      • See all
    • Public & partners
      • Find a psychiatrist
      • Annual reports & evaluations
      • For health services with STP posts
      • Media centre
      • Join the CPD Program
      • See all
    • In focus
      • Aboriginal & Torres Strait Islander mental health
      • Māori mental health
      • Gender equity
      • Rural psychiatry workforce
      • See all
    • Structure & governance
      • Committees
      • Faculties
      • Sections
      • Networks
      • Committee openings
      • Elections
      • See all
    • Tu Te Akaaka Roa NZ National Office
    • Australian branches
  • Contact
Back to results

Deep sleep therapy

Position statement Last updated: Feb 2018 Published in Australia Reference: PS#34

Deep sleep therapy has no place in the treatment of psychiatric illness. It has not been demonstrated to be an effective treatment for any psychiatric condition and has unacceptably high morbidity and mortality rates. 

Position Statement 34: Deep Sleep Therapy has been rescinded – for details about past practices in psychiatry please see Position Statement 84: Acknowledging and learning from past mental health practices.


Definition

“Deep Sleep Therapy” (also referred to as continuous narcosis or deep sedation therapy) is the term used for a procedure in which a patient is maintained (for a period of at least several days) in a comatose or semi comatose state with sedative and other psychotic drugs. The term “deep sleep” is in fact a misnomer; as such a state is not normal sleep.

Evidence

Deep Sleep Therapy was notoriously practised between 1962 and 1979 in Sydney, Australia, at the Chelmsford Private Hospital during which it was anticipated that patients' minds would be able to overcome mental afflictions. Deep Sleep Therapy was prescribed for various conditions ranging from schizophrenia, anxiety and depression to obesity and addition. This involved periods of induced coma, often for several weeks, caused by the intermittent administration of intravenous barbiturates. Many patients either died during the sleep or awoke from it with varying degrees of impairment, ranging from permanent amnesia to chronic panic. At least twenty-four patients died and many others suffered permanent physical and psychological damage at the hospital during that period (Anderson, 1991). The hospital was forced to close in the early 1980s and the Chelmsford Royal Commission was established in the 1990s to investigate the deaths that occurred there (Slattery, 1991).

Recommendations

Intermittent administration of intravenous barbiturates has no place in the treatment of psychiatric illnesses for the following reasons:

  • It has not been demonstrated to be effective in any psychiatric condition, and its administration poses particular hazards.
  • The morbidity and mortality rates associated with the practice were unacceptably high.

Responsible committee: Committee for Evidence-Based Practice


References

Anderson I (1991) Nightmare on Chelmsford. Sydney New Scientist, 5 January 1991.

Slattery JP (1991) Report of the Royal Commission into Deep Sleep Therapy. NSW Government Printer.


Disclaimer: This information is intended to provide general guidance to practitioners, and should not be relied on as a substitute for proper assessment with respect to the merits of each case and the needs of the patient. The RANZCP endeavours to ensure that information is accurate and current at the time of preparation, but takes no responsibility for matters arising from changed circumstances, information or material that may have become subsequently available. 

Your health in mind

For the public

Expert mental health information for everyone
  • Find a psychiatrist
  • Complaints about psychiatrists
  • Mental illness fact sheets

About the College

  • Offices and branches
  • Media centre
  • About us
  • For health services with STP posts

Jobs

  • Career opportunities at the College
  • Psychiatry Jobs Hub
  • Committee openings

RANZCP Head Office

309 LaTrobe Street

Melbourne VIC 3000

Australia

T: 1800 337 448 (Australia) T: 0800 443 827 (New Zealand) E: ranzcp@ranzcp.org

Contact

  • Contact the College
  • Advertising options
  • Consultation Hub

We acknowledge Aboriginal and Torres Strait Islander Peoples as the First Nations and the Traditional Owners and Custodians of the lands and waters now known as Australia, and Māori as tangata whenua in Aotearoa, also known as New Zealand.

Our commitment to Aboriginal and Torres Strait Islander mental health Our commitment to Māori mental health
© The Royal Australian and New Zealand College of Psychiatrists
  • Privacy policy
  • Terms of use